Shuning Xu
Impact in
-
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
-
- Gastric Cancer Management and Outcomes
Papers in
-
- Gastric Cancer Management and Outcomes 10
- Co-authors
- Lei Qiao (10 shared papers)Ying Liu (6 shared papers)Ke Li (2 shared papers)Jufeng Wang (2 shared papers)Fei Ma (7 shared papers)Ke Li (7 shared papers)Yi Wang (6 shared papers)Ying Liu (1 shared paper)
In The Last Decade
Shuning Xu
40 papers receiving 481 citations
Peers
Comparison fields: 5 of 94
- Cancer Research 71
- Pulmonary and Respiratory Medicine 92
- Gastroenterology 15
- Soil Science 28
- Industrial and Manufacturing Engineering 22
Countries citing papers authored by Shuning Xu
This map shows the geographic impact of Shuning Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shuning Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shuning Xu more than expected).
Fields of papers citing papers by Shuning Xu
This network shows the impact of papers produced by Shuning Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shuning Xu. The network helps show where Shuning Xu may publish in the future.
Co-authors
The 25 scholars most cited alongside Shuning Xu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 50 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | MiR-185 acts as a tumor suppressor by targeting AKT1 in non-small cell lung cancer cells. | 2015 | 53 |
| 2 | Paclitaxel plus cisplatin vs. 5-fluorouracil plus cisplatin as first-line treatment for patients with advanced squamous cell esophageal cancer. | 2016 | 47 |
| 3 | 2020 | 47 | |
| 4 | 2023 | 30 | |
| 5 | 2018 | 22 | |
| 6 | 2015 | 22 | |
| 7 | 2020 | 21 | |
| 8 | 2021 | 20 | |
| 9 | 2022 | 18 | |
| 10 | 2024 | 14 | |
| 11 | 2020 | 14 | |
| 12 | 2023 | 13 | |
| 13 | 2018 | 12 | |
| 14 | 2020 | 12 | |
| 15 | 2015 | 9 | |
| 16 | 2024 | 9 | |
| 17 | 2023 | 8 | |
| 18 | 2019 | 8 | |
| 19 | 2022 | 8 | |
| 20 | 2021 | 8 |
About Shuning Xu
Shuning Xu is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology, Computer Vision and Pattern Recognition, Oncology and Surgery, having authored 50 papers that have together received 484 indexed citations. Recurring topics across this work include Gastric Cancer Management and Outcomes (10 papers), Advanced Image Processing Techniques (4 papers), Esophageal Cancer Research and Treatment (4 papers), Colorectal Cancer Treatments and Studies (3 papers), Gastrointestinal Tumor Research and Treatment (3 papers), Cancer-related molecular mechanisms research (3 papers), Image Enhancement Techniques (3 papers) and Advanced Vision and Imaging (3 papers). The work is most often cited by research in Cancer Research (71 citations), Pulmonary and Respiratory Medicine (92 citations), Gastroenterology (15 citations), Soil Science (28 citations) and Industrial and Manufacturing Engineering (22 citations). Shuning Xu has collaborated with scholars based in China, Macao and Singapore. Frequent co-authors include Lei Qiao, Ying Liu, Ke Li, Jufeng Wang, Fei Ma, Ke Li, Yi Wang, Ying Liu, Shuai Li and Xinfang Hou. Their work appears in journals such as Frontiers in Immunology, European Radiology, Journal of Clinical Oncology, Abdominal Radiology and European Journal of Surgical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.